生物活性 | |||
---|---|---|---|
描述 | NCGC00229600 is characterized as an allosteric inverse agonist for the thyrotropin receptor (TSHR), effectively inhibiting the activation of TSHRs by both thyroid-stimulating hormone (TSH) and stimulating antibodies found in Graves' disease. This highlights its potential for therapeutic applications in treating conditions related to thyroid dysfunction[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.09mL 0.42mL 0.21mL |
10.43mL 2.09mL 1.04mL |
20.85mL 4.17mL 2.09mL |
参考文献 |
---|